Legend Biotech (LEGN) Change in Accured Expenses (2020 - 2025)

Legend Biotech (LEGN) has 6 years of Change in Accured Expenses data on file, last reported at $6.8 million in Q3 2025.

• In Q3 2025, Change in Accured Expenses rose 552.75% year-over-year to $6.8 million; the TTM figure through Sep 2025 stood at -$12.5 million (down 116.72% YoY), while the FY2024 annual figure was $45.7 million, up 3587.94% from the prior year.
• Change in Accured Expenses fell to $6.8 million in Q3 2025, from $20.9 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $77.0 million in Q4 2021 and bottomed at -$39.2 million in Q1 2023.
• A 5-year average of $15.4 million and a median of $7.4 million in 2024 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses surged 1476.25% — and 2025, when it slumped 623.51%.
• Year by year, Change in Accured Expenses stood at $77.0 million in 2021, then plunged by 97.73% to $1.7 million in 2022, then surged by 1476.25% to $27.5 million in 2023, then tumbled by 105.36% to -$1.5 million in 2024, then soared by 558.97% to $6.8 million in 2025.
• The last three Change in Accured Expenses figures came in at $6.8 million (Q3 2025), $20.9 million (Q2 2025), and -$38.6 million (Q1 2025), per Business Quant data.

Peer Comparison